Jules Remenar is a Research Fellow at Alkermes in Watham, MA where his work is focused on understanding the physical behavior of drug molecules as they interact with formulation components during manufacture, on storage, and after dosing.
Dr. Remenar received a Bachelors degree in chemistry from Michigan State University in 1991 and a Ph.D. in physical-organic chemistry from Cornell University in 1996. He completed studies in polymers and materials science as a postdoctoral fellow working jointly between the IBM Almaden Research Center and Stanford.
He began his pharmaceutical career at Merck in Rahway, NJ in 1997, moved to Transform Pharmaceuticals in 2002, and moved to Alkermes in 2008. At Merck, he was responsible for building a new pharmaceutical chemistry group to support basic research activities in Rahway, NJ. At Transform Pharmaceuticals/J&J he was responsible for improving the oral bioavailability of poorly soluble drug molecules and avoiding/overcoming physical and chemical stability problems in drug products. Through this work, he became interested in pharmaceutical cocrystals and in understand- ing where they fit into the spectrum of development options. At Alkermes, he has turned his attention to long-acting, injectable antipsychotics, through design of slowly dissolving crystalline prodrugs and through the understand- ing of phase behavior within polymeric microspheres.